Status:
RECRUITING
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Lead Sponsor:
Casa di Cura San Raffaele Cassino
Collaborating Sponsors:
IRCCS San Raffaele Roma
San Raffaele Telematic University
Conditions:
Neurodegenerative Diseases
Parkinson Disease
Eligibility:
All Genders
10+ years
Brief Summary
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations ...
Detailed Description
Considering the current estimates and the global social and economic burden of neurodegenerative diseases, changes in the manner and timing of a diagnosis of these diseases are urgently needed as well...
Eligibility Criteria
Inclusion
- Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disorders
- Patients with diagnosis of Parkinson's Disease
- Diagnosis of Parkinson's Disease according to the United Kingdom (UK) Parkinson's Disease Society Brain Bank
- Diagnosis of Movement Disorder not related to Parkinson's Disease
- Diagnosis of Multiple System Atrophy (MSA) in accordance with Second Consensus Statement on Diagnosis of Multiple System Atrophy;
- Diagnosis of Progressive Supranuclear Palsy according to Movement Disorder Society for Diagnosis of Progressive Supranuclear Palsy;
- Diagnosis of Essential Tremor
- Willing to participate in the study, understand the procedures and sign the informed consent.
- Patients affected by cognitive impairment (CI) and dementia
- Diagnosis of probable:
- Lewy Body Dementia
- Alzheimer's Disease
- Mild Cognitive Decline
- Subjective memory complaints
- Willing to participate in the study, understand the procedures and sign the informed consent.
Exclusion
- There are no restrictions for participation in the study based on age, severity of illness or presence of cognitive impairment, as long as the person is able to complete the research assessments.
Key Trial Info
Start Date :
September 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 9 2034
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06596746
Start Date
September 9 2024
End Date
September 9 2034
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Raffaele Cassino
Cassino, Frosinone, Italy, 03043